Top Markets
Coin of the day
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rang in Aktien #15163
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Aktienkurs
$1.98
Marktkapitalisierung
$368.99M
Veränderung (1 Tag)
0.90%
Veränderung (1 Jahr)
11.38%
Land
AU
Handel Australian Clinical Labs Limited (ACL)

Kategorie

Kursverlauf für Australian Clinical Labs Limited (ACL)
Höchster Schlusskurs: $1.98 am 2026-09-01

Niedrigster Schlusskurs: $2.77 am 2021-05-01
Kursverlauf der Aktie von Australian Clinical Labs Limited von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.37%
2025 -17.41%
2024 18.72%
2023 -9.09%
2022 -42.56%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$618.84 25.60%
US
$213.90 3.93%
US
$22.13 41.40%
CN
$319.66 89.99%
US
$557.63 -13.82%
US